RTAC: FES/Cerianna Screening for Estrogen Positive MBC

RTAC: FES/Cerianna Screening for Estrogen Positive MBC

There’s a FDA- approved diagnostic imaging agent developed to comprehensively evaluate estrogen receptor-positive (ER+) lesions in recurrent or metastatic breast cancer as an adjunct to biopsy. By creating a “whole-body” picture of ER+ lesions, Cerianna may be a helpful diagnostic tool in helping oncologists better determine the most appropriate course of treatment. Learn more in this episode.

Read More
Dr. Lidia Schapira: Hey Doc, What Are You Telling Me?

Dr. Lidia Schapira: Hey Doc, What Are You Telling Me?

What can we, as patients, do to strengthen our communication and relationships with our oncologists? This episode of Our MBC Life, the first in our MBC 101 series, includes perspectives, insights and suggestions from both sides of the critical doctor-patient relationship

Read More